| Autor: |
Larson, Paul S., Björklund, Anders, Bloem, Bastiaan R., Brundin, Patrik, Federoff, Howard |
| Předmět: |
|
| Zdroj: |
Journal of Parkinson's Disease; 2021 Supplement 2s, Vol. 11, pS199-S206, 8p |
| Abstrakt: |
A number of cell transplantation and gene therapy trials have been performed over the last three decades in an effort to restore function in Parkinson's disease. Much has been learned about optimizing delivery methods for these therapeutics. This is particularly true in gene therapy, which has predominated the clinical trial landscape in recent years; however, cell transplantation for Parkinson's disease is currently undergoing a renaissance. Innovations such as cannula design, iMRI-guided surgery and an evolution in delivery strategy has radically changed the way investigators approach clinical trial design. Future therapeutic strategies may employ newer delivery methods such as chronically implanted infusion devices and focal opening of the blood brain barrier with focused ultrasound. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
